Nitric Oxide Signaling in Cardiovascular Physiology and Pathology: Mechanisms, Dysregulation, and Therapeutic Frontiers
International Journal of Molecular Sciences · 08.01.2026 · 27 (2) · 629
DOI: 10.3390/ijms27020629 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.01.2026. Verfasst von Sakthipriyan Venkatesan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Physiology, Department of Translational Medicine, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy. Hauptthemen laut MEDLINE: Nitric Oxide, Signal Transduction, Cardiovascular Diseases, Cardiovascular Physiological Phenomena. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nitric oxide (NO), a fundamental gaseous signaling molecule, is indispensable for cardiovascular homeostasis. This review synthesizes the expansive field of NO biology within the unifying framework of Nitric Oxide Equilibrium (NOE), i.e., the critical balance between its synthesis, bioavailability, and degradation. In a physiological state, NOE maintains vascular health by regulating blood pressure, preventing thrombosis, suppressing inflammation, and optimizing both cardiac and mitochondrial function. Here, we analyze how NOE disruption, primarily through oxidative stress and enzymatic dysfunction, underlies the pathogenesis of major cardiovascular diseases, including atherosclerosis, heart failure, ischemia–reperfusion injury, and cerebrovascular diseases like stroke. A critical evaluation of therapeutic strategies designed to restore NOE is presented, encompassing classic NO donors and phosphodiesterase-5 inhibitors, alongside next-generation soluble guanylate cyclase modulators and precision nanomedicine approaches. By identifying key knowledge gaps and methodological hurdles, this review charts a course for future research focused on biomarker-guided interventions and personalized medicine. Ultimately, we frame the restoration of NOE as a paramount therapeutic goal, crucial to translating decades of molecular research into effective clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Physiology, Department of Translational Medicine, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.
- Internal Medicine Unit, Department of Translational Medicine, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.
- Gynecology and Obstetrics Unit, Department of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy.
ORCID-Profile: Sakthipriyan Venkatesan, Carlo Smirne, Carmen Imma Aquino, Daniela Surico, Valentino Remorgida, Mohammad Mostafa Ola Pour, Mario Pirisi, Elena Grossini
Zitieren
APA
Venkatesan, S., Smirne, C., Aquino, C. I., Surico, D., Remorgida, V., Ola Pour, M. M., Pirisi, M., & Grossini, E. (2026). Nitric Oxide Signaling in Cardiovascular Physiology and Pathology: Mechanisms, Dysregulation, and Therapeutic Frontiers. International Journal of Molecular Sciences, 27(2), 629. https://doi.org/10.3390/ijms27020629
Vancouver
Venkatesan S, Smirne C, Aquino CI, Surico D, Remorgida V, Ola Pour MM, et al. Nitric Oxide Signaling in Cardiovascular Physiology and Pathology: Mechanisms, Dysregulation, and Therapeutic Frontiers. International Journal of Molecular Sciences. 2026;27(2):629. doi:10.3390/ijms27020629
BibTeX
@article{Venkatesan2026,
author = {Venkatesan, Sakthipriyan and Smirne, Carlo and Aquino, Carmen Imma and Surico, Daniela and Remorgida, Valentino and Ola Pour, Mohammad Mostafa and Pirisi, Mario and Grossini, Elena},
title = {Nitric Oxide Signaling in Cardiovascular Physiology and Pathology: Mechanisms, Dysregulation, and Therapeutic Frontiers},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {2},
pages = {629},
doi = {10.3390/ijms27020629}
}
EUVIMED